Premium
An evaluation of the quality and impact of the global research response to the COVID ‐19 pandemic
Author(s) -
Ramanan Mahesh,
Stolz Annaliese,
Rooplalsingh Rajiv,
Billot Laurent,
Myburgh John,
Venkatesh Bala
Publication year - 2020
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/mja2.50790
Subject(s) - pandemic , medicine , lopinavir , hydroxychloroquine , middle east respiratory syndrome , psychological intervention , covid-19 , ritonavir , randomized controlled trial , middle east respiratory syndrome coronavirus , clinical trial , intensive care medicine , virology , virus , viral load , disease , infectious disease (medical specialty) , psychiatry , antiretroviral therapy
To the Editor: The initial months of the coronavirus disease 2019 (COVID19) pandemic have led to an unprecedented response from the global medical research community.1 Simultaneously, there have been concerns about the rapid publication of misleading, biased studies.2 We systematically evaluated the early global research response to COVID19 by characterising the methodological quality of registered COVID19 studies. We also compared the research response with previous respiratory viral epidemics: the severe acute respiratory syndrome (SARS), the Middle East respiratory syndrome (MERS) and the influenza A(H1N1) pdm09 virus pandemic.